Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 1c Apr 28, 2026 04:24PM
KeyBanc Starts Inventrust Properties Corp. (IVT) at Overweight Mar 6, 2026 12:58AM
Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 5c; offers guidance Feb 10, 2026 04:25PM
Miv Therapeutics, Inc. (IVT) Tops Q3 EPS by 1c Oct 28, 2025 04:03PM
JPMorgan Starts Inventrust Properties Corp. (IVT) at Neutral Oct 17, 2025 02:03AM


Jul 29, 2025 04:41PM Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 117c; updates guidance
Jun 20, 2025 04:05PM InvenTrust Properties Corp (IVT) Declares $0.2377 Quarterly Dividend; 3.4% Yield
May 3, 2025 04:00PM Sizing up tariff risk for REITs
Apr 30, 2025 04:43PM Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 2c, provides guidance
Mar 13, 2025 04:04PM InvenTrust Properties Corp (IVT) Raises Quarterly Dividend 4.4% to $0.2376; 3.3% Yield
Feb 19, 2025 04:03PM InvenTrust Properties Corp (IVT) appoints Julie Swinehart to Board
Feb 11, 2025 04:20PM Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 8c
Jan 5, 2025 10:00AM 2025 retail REIT outlook according to Jefferies
Jan 2, 2025 03:26AM Jefferies Upgrades Inventrust Properties Corp. (IVT) to Buy
Nov 19, 2024 05:35AM Jefferies Starts Inventrust Properties Corp. (IVT) at Hold
Oct 29, 2024 04:27PM Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c
Oct 3, 2024 05:18AM BofA Securities Upgrades Inventrust Properties Corp. (IVT) to Buy
Sep 24, 2024 06:21AM InvenTrust Properties Corp (IVT) Prices Upsized 8M Share Offering at $28/sh
Sep 23, 2024 04:05PM InvenTrust Properties Corp (IVT) Announces 6.5M Share Offering